Susquehanna International Group, LLP Cytosorbents Corp Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Cytosorbents Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 11,033 shares of CTSO stock, worth $10,150. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,033

Previous 89,788 87.71%

Holding current value

$10,150

Previous $62,000 74.19%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.7 - $1.55 $55,128 - $122,070	-78,755 Reduced 87.71%	11,033 $16,000
Q2 2024 Aug 15, 2024	BUY	$0.7 - $1.01 $51,513 - $74,325	73,590 Added 454.32%	89,788 $62,000
Q1 2024 May 07, 2024	BUY	$0.86 - $1.07 $13,930 - $17,331	16,198 New	16,198 $15,000
Q2 2023 Aug 11, 2023	SELL	$2.37 - $3.65 $99,833 - $153,752	-42,124 Reduced 79.56%	10,820 $38,000
Q1 2023 May 16, 2023	BUY	$1.79 - $4.17 $37,591 - $87,574	21,001 Added 65.75%	52,944 $178,000
Q4 2022 Feb 14, 2023	BUY	$1.03 - $2.03 $15,018 - $29,599	14,581 Added 83.98%	31,943 $49,000
Q3 2022 Nov 14, 2022	SELL	$1.2 - $2.46 $40,680 - $83,394	-33,900 Reduced 66.13%	17,362 $24,000
Q2 2022 Aug 15, 2022	BUY	$1.76 - $3.22 $48,002 - $87,822	27,274 Added 113.7%	51,262 $112,000
Q4 2021 Feb 14, 2022	BUY	$4.05 - $8.11 $13,012 - $26,057	3,213 Added 15.47%	23,988 $101,000
Q3 2021 Nov 15, 2021	SELL	$7.0 - $9.71 $271,586 - $376,728	-38,798 Reduced 65.13%	20,775 $169,000
Q2 2021 Aug 11, 2021	SELL	$7.55 - $9.42 $118,263 - $147,554	-15,664 Reduced 20.82%	59,573 $450,000
Q1 2021 May 17, 2021	BUY	$8.23 - $11.48 $193,800 - $270,331	23,548 Added 45.56%	75,237 $653,000
Q4 2020 Feb 16, 2021	SELL	$7.65 - $8.98 $169,485 - $198,951	-22,155 Reduced 30.0%	51,689 $412,000
Q3 2020 Nov 16, 2020	BUY	$7.37 - $11.54 $42,871 - $67,128	5,817 Added 8.55%	73,844 $589,000
Q2 2020 Aug 14, 2020	SELL	$6.28 - $10.59 $367,555 - $619,811	-58,528 Reduced 46.25%	68,027 $673,000
Q1 2020 May 15, 2020	BUY	$3.77 - $7.73 $378,779 - $776,648	100,472 Added 385.2%	126,555 $978,000
Q4 2019 Feb 14, 2020	SELL	$3.61 - $5.22 $66,824 - $96,627	-18,511 Reduced 41.51%	26,083 $100,000
Q3 2019 Nov 14, 2019	BUY	$4.33 - $7.63 $26,616 - $46,901	6,147 Added 15.99%	44,594 $224,000
Q2 2019 Aug 16, 2019	BUY	$5.92 - $7.78 $7,879 - $10,355	1,331 Added 3.59%	38,447 $254,000
Q2 2019 Aug 14, 2019	BUY	$5.92 - $7.78 $157,051 - $206,395	26,529 Added 250.58%	37,116 $245,000
Q1 2019 May 15, 2019	SELL	$6.82 - $8.56 $714,954 - $897,361	-104,832 Reduced 90.83%	10,587 $80,000
Q1 2018 May 15, 2018	BUY	$6.55 - $8.2 $350,490 - $438,781	53,510 Added 86.43%	115,419 $814,000
Q4 2017 Feb 14, 2018	SELL	$5.9 - $7.05 $690,860 - $825,519	-117,095 Reduced 65.41%	61,909 $402,000
Q3 2017 Nov 14, 2017	BUY	$4.5 - $6.2 $805,518 - $1.11 Million	179,004	179,004 $1.11 Million

Others Institutions Holding CTSO

# of Institutions

Shares Held

16.7M

Call Options Held

15.4K

Put Options Held

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $40.1M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Cytosorbents Corp Transaction History